News: Endologix Inc (ELGX.O)

ELGX.O on Consolidated Issue listed on NASDAQ Global Market

5.28USD
23 Dec 2009
Price Change (% chg)

$0.10 (+1.93%)
Prev Close
$5.18
Open
$5.20
Day's High
$5.38
Day's Low
$5.18
Volume
86,937
Avg. Vol
329,090
52-wk High
$6.27
52-wk Low
$0.97

view news for:
Select another date:

Fri, Oct 9 2009

HEADLINE STOCKS-Some U.S. stocks on the move on Oct. 9

NEW YORK, Oct 9 (Reuters) - Some U.S. stocks on the move on Friday:

HEADLINE STOCKS-Some U.S. stocks on the move on Oct. 9

(Updates to after the open, adds Citigroup/Occidental, AK Steel, Sunrise, Acorda, MDS, Kimberly Clark/I-Flow, Scientific Learning)

UPDATE 1-Endologix raises 2009 rev view

March 23 (Reuters) - Medical device maker Endologix Inc raised its 2009 revenue view and forecast first-quarter revenue above market estimates on better-than-expected adoption of its recently approved delivery system, IntuiTrak.

UPDATE 1-Endologix says gets unsolicited bid from hedge fund

(Recasts; adds details, background) Oct 15 (Reuters) - Endologix Inc said it received an unsolicited takeover bid from hedge fund Elliott Associates LP for $2.25 a share, 18 percent higher than the stock's Wednesday closing price.

BRIEF-Endologix sees total 2007 revenue of $27.8 mln

Jan 7 (Reuters) - ENDOLOGIX INC : * Endologix expects total 2007 revenue of $27.8 million * Forecasts fourth quarter revenue about $8 million * Forecasts 2008 product revenue $39 million to $43 million * Forecasts 2008 gross margin to range from 71 percent to 75 percent * Forecasts 2008 total operating expenses $35- $39 million * Reuters Estimates fiscal year 2007 revenue view $27.48 mln

TABLE-Endologix Q2 net loss narrows

ENDOLOGIX INC. (in $) Latest Yr-ago qtr Loss/shr (diluted) 0.09 0.11 Net loss (million) 3.7 4.4 Total revenue (million) 6.3 3.5 Reuters Estimates: Loss/shr $0.10, revenue $6.6 million. (Reporting by Aditi Samajpati in Bangalore)

Select another date:
view news for: